Itamar Medical Inc
$778.2K 1,600 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Acessa Health Inc.
Acessa Health Inc. reported $780,920.29 across General Payments, Research, and Ownership to 430 physicians and teaching hospitals across 434 transactions.
- $780.9K Above-median payer
- All-tracks total
- 434 Above-median volume
- Transactions
- 430 Above-median reach
- Recipients
- −$1.4M
- General Payments vs PY2023
Acessa Health Inc. reported $780,920.29 across all CMS Open Payments tracks (General + Research + Ownership) to 430 physicians and teaching hospitals in Program Year 2024 - ranking #676 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $767,193.79, averaging $1.8K per recipient.
How Acessa Health Inc.'s $780.9K all-tracks total breaks down
Acessa Health Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
20/100
Total payments
F
17/100
Transaction volume
F
13/100
Physician reach
F
13/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer acessa-health-inc Acessa Health Inc.
$780.9K · #676/1,925 · 0.0% industry · PY2024
- TOT $780.9K
- RANK #676
- SHARE 0.0%
- TXN 434
- RCP 430
- CAT 3
- GEN $767.2K
- ΔGEN −$1.4M
- TOP1 18.4%
- PY 2024
Volume peers
Nearest volume peer: Itamar Medical Inc ($778.2K)
Acessa Health Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Acessa Health Inc.'s CMS-reported General Payments decreased by $1.4M (−65.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ACESSA HEALTH INC.PY2023: ACESSA HEALTH INC.PY2024: Acessa Health Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $2,208,585.18
- PY2024
- $767,193.79
What the Data Shows for Acessa Health Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Acessa Health Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 3 general-payment categories charted below, "Consulting Fee" is the largest at $731.1K across 220 transactions, 95.3% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 3 types of general payments, Acessa Health Inc.'s largest category was "Consulting Fee" at $731.1K - 95.3% of General Payments.
How Acessa Health Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $731.1K | 220 | 95.3% |
| Travel and Lodging | $31.1K | 134 | 4.1% |
| Food and Beverage | $5.0K | 76 | 0.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $454,653.24 (59.3%) of $767,193.79 in this company's General Payments records across 39 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Acessa Health Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Steve Yu
$140,909.37 across 59 reported transactions
- 2
Otis Lawrence Stitt
$124,671.76 across 71 reported transactions
- 3
Linda Lacy
$76,410.09 across 40 reported transactions
- 4
Keith Aqua
$63,266.34 across 35 reported transactions
- 5
Keith Ramsey
$49,395.68 across 15 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Acessa Health Inc. ranks #676 of 1,925 by total payments (top 35% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,060 of 1,838 by HHI (bottom 42% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Neoss, Inc. : $107.6K total payments, HHI 934
- Acist Medical Systems, Inc. : $163.3K total payments, HHI 931
- USA Angelalign Technology Corp : $100.0K total payments, HHI 930
- IntrinsiQ Specialty Solutions, Inc. : $1.3K total payments, HHI 926
- Precision Medical Products Inc. : $832.29 total payments, HHI 924
- CPM Medical Consultants, LLC : $2.4K total payments, HHI 919
- Acessa Health Inc. (this company) : $767.2K total payments, HHI 919
- Ortho Development Corporation : $3.6M total payments, HHI 918
- EDW Pharma, Inc. : $2.6K total payments, HHI 916
- Onkos Surgical, Inc. : $402.3K total payments, HHI 915
- Kinex Medical Company LLC : $133.04 total payments, HHI 915
- Choice Spine, LLC : $1.0M total payments, HHI 912
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Acessa Health Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Acessa Health Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Acessa Health Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Terumo BCT, Inc.
$778.0K 32 recipients
Compare payment profiles
LinkBio Corp
$776.2K 447 recipients
Compare payment profiles
Kalitec Direct LLC
$790.7K 24 recipients
Compare payment profiles
Dr.Reddy's Laboratories,Inc.
$792.9K 68 recipients
Compare payment profiles
Affordable Pharmaceuticals, LLC
$766.7K 8 recipients
Compare payment profiles
Put this to use
Acessa Health Inc. ranks #676 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Acessa Health Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.